
The discontinuation of statin therapy in healthy individuals 75 years of age and older was associated with an increased risk for developing cardiovascular disease.
The new study, published in the European Heart Journal, was a survey of 120,173 individuals in France aged 75 or older with no history of cardiovascular disease. The participants had been taking statins for two years prior. The authors defined statin discontinuation as three consecutive months without exposure, and the primary study outcome was hospital admission for a cardiovascular event. The researchers estimated the hazard ratios of statin continuation versus discontinuation with a marginal structural model. Subjects were followed for an average of 2.4 years.
According to the results, 17,204 (14.3%) of subjects discontinued statins and 5,396 were admitted for cardiovascular events. Adjusted hazard ratios for statin discontinuation were 1.33 (95% CI, 1.18 to 1.50) for any cardiovascular event, 1.46 (95% CI, 1.21 to 1.75) for coronary events, 1.26 (95% CI, 1.05 to 1.51) for a cerebrovascular event, and 1.02 (95% CI, 0.74 to 1.40) for other vascular events.